Boston Therapeutics, Inc. announced that on January 10, 2020, Conroy Cheng was appointed to serve as the Interim Chief Executive Officer and Interim Chief Financial Officer of the Company. On December 12, 2019, Carl Rausch resigned as a member of the Board of Directors and as an executive officer of Boston Therapeutics, Inc. The resignation is not as a result of any disagreement between Mr. Rausch and the Company. The Company intends to engage Mr. Rausch as a pharma consultant to address the next phase of the Company's broader clinical development.

There is no understanding or arrangement between Mr. Cheng and any other person pursuant to which he was appointed as an executive officer and director.